$6.46 3%
Price vs. AI Score (Last 150 days)
Data gathered: November 29

Data Bits

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Axogen

AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide.

Price $6.46
Target Price Sign up
Market Cap $257M
Dividend Yield 0.0261
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2341M8M33M-4.1M-4M
Q2 '2338M7.2M31M-6.7M-6.8M
Q1 '2337M6.7M30M-7.1M-7.3M
Q4 '2236M6.1M30M-5.4M-5.5M
Q3 '2237M6.2M31M-4.3M-4.8M

Insider Transactions

Wendell Amy McBride filed to buy 80,342 shares at $6.2.
September 8 '23
Burke William P. Mr. filed to buy 10,000 shares at $6.6.
August 25 '23
NEELS GUIDO J filed to buy 68,259 shares at $6.1.
August 18 '23
Freitag Gregory Gene filed to sell 290,135 shares at $8.7.
June 5 '23
Freitag Gregory Gene filed to sell 332,115 shares at $9.3.
May 24 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.